Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 51Neoplasm Metastasis 19Skin Neoplasms 15Carcinoma, Renal Cell 13Leukemia, Myeloid, Acute 12Kidney Neoplasms 11Leukemia 9Neoplasms 7Uterine Cervical Neoplasms 5Lymphoma 5Congenital Abnormalities 5Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neuroblastoma 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Carcinoma, Non-Small-Cell Lung 4Vaginal Neoplasms 2Penile Neoplasms 2Papillomavirus Infections 2Oropharyngeal Neoplasms 2Melanoma, Experimental 2Lymphoma, Mantle-Cell 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Erythroblastic, Acute 2Brain Neoplasms 2

Interventions

fludarabine phosphate 2aldesleukin 2Cyclophosphamide 2fludarabine 1Whole-Body Irradiation 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Melanoma, Experimental × aldesleukin × Clear all
NCT00513604 2013-06-03

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
158 enrolled 14 charts
Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms, Skin Neoplasms

NCT00924001 2012-10-25

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
1 enrolled 8 charts
Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡